跳至主要内容
临床试验/DRKS00005263
DRKS00005263招募中未知

Diagnostic performance of Prostate HistoScanningTM (PHS) in men at risk of prostate cancer scheduled for an initial prostate biopsy. - PHSTT-01

Advanced Medical Diagnostics SAWaterloo Office Park Bât i bte 30 个研究点目标入组 391 人开始时间: 2014年3月13日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
391

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • Men at risk of PCa scheduled for first biopsy with serum total PSA
  • = 20 ng/ml (= 10 ng/mL if taking 5-alpha reductase inhibitors) from maximally 3 months ago
  • Signed informed consent

排除标准

  • Previous prostate biopsy
  • Confirmed PCa
  • PSA > 20 ng/ml (or > 10 ng/mL if taking 5-alpha reductase inhibitors)
  • Active urinary tract infection
  • Presence/history of any confirmed cancer
  • Recent prostatic surgery (past 6 months)
  • History of pelvic radiotherapy

研究者

发起方
Advanced Medical Diagnostics SAWaterloo Office Park Bât i bte 3

相似试验